358 related articles for article (PubMed ID: 2577478)
1. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
Chelvam P; Wong EC
J Gastroenterol Hepatol; 1989; 4 Suppl 2():75-81. PubMed ID: 2577478
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of omeprazole as a treatment for gastric and prepyloric ulcer in Korean patients.
Sun HS; Choi KW; Yoon CM; Park KN; Min YI; Lee SI; Chung JM; Yang US
J Gastroenterol Hepatol; 1989; 4 Suppl 2():69-74. PubMed ID: 2491364
[TBL] [Abstract][Full Text] [Related]
3. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderly.
Pilotto A; Di Mario F; Battaglia G; Vigneri S; Leandro G; Franceschi M; De Boni M; Grasso A; Vianello F; Naccarato R
Clin Ther; 1994; 16(6):935-41. PubMed ID: 7697690
[TBL] [Abstract][Full Text] [Related]
5. Omeprazole 20 mg and 40 mg daily in the treatment of gastric ulcer: a pilot study in Filipino patients.
Gloria VI; Domingo EO; Makalinao AU; Zano FM; Rasco ET; Sy CT
J Gastroenterol Hepatol; 1989; 4 Suppl 2():63-8. PubMed ID: 2491363
[TBL] [Abstract][Full Text] [Related]
6. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
[TBL] [Abstract][Full Text] [Related]
7. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
8. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness and safety of lansoprazole in the treatment of peptic ulcer].
Ramón Nogueira J; Esquivel Ayanegui F; Esquivel Rodríguez F; Sáenz V; Santoyo R
Rev Gastroenterol Mex; 1996; 61(4):314-9. PubMed ID: 9072782
[TBL] [Abstract][Full Text] [Related]
10. Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs.
Di Mario F; Gottardello L; Germanà B; Dotto P; Grassi SA; Vianello F; Battaglia G; Leandro G; Burra P; Salvagnini M
Ital J Gastroenterol; 1992; 24(3):122-5. PubMed ID: 1348650
[TBL] [Abstract][Full Text] [Related]
11. Short- and long-term omeprazole for the treatment and prevention of duodenal ulcer, and effect on Helicobacter pylori.
Marzio L; Biasco G; Cifani F; DeFanis C; Falcucci M; Ferrini G; Grossi L; Iannetti G; Larcinese G; Lattanzio R
Am J Gastroenterol; 1995 Dec; 90(12):2172-6. PubMed ID: 8540510
[TBL] [Abstract][Full Text] [Related]
12. Refractory duodenal ulcer healing and relapse: comparison of omeprazole with Helicobacter pylori eradication.
Avsar E; Kalayci C; Tözün N; Lawrence R; Kiziltas S; Gültekin O; Ulusoy NB
Eur J Gastroenterol Hepatol; 1996 May; 8(5):449-52. PubMed ID: 8804873
[TBL] [Abstract][Full Text] [Related]
13. Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in Thai patients with peptic ulcer disease.
Wongkusoltham P; Vilaichone RK; Kullavanijaya P; Phaosawadi K; Mahachai V
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S474-80. PubMed ID: 11529378
[TBL] [Abstract][Full Text] [Related]
14. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
[TBL] [Abstract][Full Text] [Related]
15. Omeprazole in the treatment of peptic ulcers resistant to H2-receptor antagonists.
Guerreiro AS; Neves BC; Quina MG
Aliment Pharmacol Ther; 1990 Jun; 4(3):309-13. PubMed ID: 1983325
[TBL] [Abstract][Full Text] [Related]
16. Multicenter evaluation of dual-therapy (omeprazol and amoxycillin) for Helicobacter pylori-associated duodenal and gastric ulcer (two years of the observation).
Gabryelewicz A; Laszewicz W; Dzieniszewski J; Ciok J; Marlicz K; Bielecki D; Popiela T; Legutko J; Knapik Z; Poniewierka E
J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():93-105. PubMed ID: 9440060
[TBL] [Abstract][Full Text] [Related]
17. The effect of omeprazole and ranitidine on ulcer healing, relief of symptoms, and incidence of adverse events in the treatment of duodenal ulcer patients.
Kager L; Lindberg G; Nilsson LH; Seensalu R; Backman L; Granström L; Kollberg B; Sidenvall L; Moberg S; Sörstad J
Hepatogastroenterology; 1991 Aug; 38(4):287-90. PubMed ID: 1937372
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with omeprazole: assessment of efficacy and safety.
Walan A
J Gastroenterol Hepatol; 1989; 4 Suppl 2():27-33. PubMed ID: 2491359
[TBL] [Abstract][Full Text] [Related]
19. [Omeprazole in the therapy of acid-induced diseases].
Simon B; Dammann HG; Müller P
Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
[TBL] [Abstract][Full Text] [Related]
20. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
